Urinary System Adenocarcinoma — Trials

Urinary System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 378
Recruiting: 195
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (279)

clinicaltrialsPublishedShowing 101–106 of 106 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04787042	Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067	recruiting	Phase 1 / Phase 2	316	Simcha IL-18, Inc.INDUSTRY	1	Nov 15, 2024	clinicaltrials
NCT06690697	Combination of Toripalimab and JS004 Therapy for ccRCC	recruiting	Phase 2	80	Fudan UniversityOTHER	1	Nov 15, 2024	clinicaltrials
NCT06613269